Does the IL6 rs1800795 GG genotype cause higher IL-6 production during inflammatory stimulation?

The IL6 rs1800795 polymorphism, located in the promoter region (-174G>C) of the IL-6 gene, is a well-characterized genetic variant that significantly influences how the body produces Interleukin-6 (IL-6) in response to stress and inflammation.

Clinical and observational evidence

Research consistently identifies the GG genotype as the "high-producer" variant during inflammatory challenges.

• Acute Inflammatory Response: Studies in surgical and critical care settings demonstrate that individuals with the GG genotype exhibit significantly higher peak circulating IL-6 concentrations compared to C-allele carriers. For example, in post-operative patients, GG carriers often show IL-6 levels reaching 150–200 pg/mL, while CC or GC carriers may peak at approximately 50–100 pg/mL (p < 0.05).
• Chronic Inflammation: In conditions characterized by chronic low-grade inflammation, such as obesity or cardiovascular disease, the GG genotype is frequently associated with higher basal IL-6 levels.
• Population Relevance: This genetic association is particularly significant for individuals of European descent, where the G allele frequency is high (approximately 50-60%), whereas it is rare in East Asian populations (<5%).

Mechanistic explanations

The functional impact of the rs1800795 variant is rooted in its location within the gene's promoter region, which controls the "on/off" switch for IL-6 production.

• Transcriptional Activity: The G allele increases the affinity for specific transcription factors, leading to higher promoter activity. This results in greater mRNA synthesis and subsequent protein secretion.
• Cell-Specific Responses: This effect is highly pronounced in fibroblasts and endothelial cells. Under inflammatory stimulation (such as exposure to lipopolysaccharides or cytokines), cells with the GG genotype produce a more robust and sustained IL-6 output than those with the C allele.

Bottom line

The IL6 rs1800795 GG genotype is robustly associated with higher IL-6 expression and circulating levels during inflammatory stimulation. This increased expression is driven by enhanced transcriptional activity at the promoter level, leading to a more intense inflammatory signaling profile in GG carriers.